Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT01857193 |
Title | Phase Ib Trial of LEE011 With Everolimus (RAD001) and Exemestane in the Treatment of Hormone Receptor Positive HER2 Negative Advanced Breast Cancer |
Recruitment | Completed |
Gender | female |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Novartis Pharmaceuticals |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | FRA | ESP | BEL |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Highlands Oncology Group | Fayetteville | Arkansas | 72703 | United States | Details | |
Sylvester Comprehensive Cancer Center Main Center | Miami | Florida | 33136 | United States | Details | |
Massachusetts General Hospital Onc Dept | Boston | Massachusetts | 02114 | United States | Details | |
Karmanos Cancer Institute Dept of Onc | Detroit | Michigan | 48201 | United States | Details | |
Memorial Sloan Kettering Oncology Dept. | New York | New York | 10017 | United States | Details | |
Oregon Health and Science University SC-5 | Portland | Oregon | 97239 | United States | Details | |
University of Texas MD Anderson Cancer Center Onc Dept | Houston | Texas | 77030 | United States | Details | |
Northwest Medical Specialties | Tacoma | Washington | 98405 | United States | Details | |
Novartis Investigative Site | Wilrijk | 2610 | Belgium | Details | ||
Novartis Investigative Site | Saint Herblain cedex | 44805 | France | Details | ||
Novartis Investigative Site | Hong Kong | Hong Kong | Details | |||
Novartis Investigative Site | Barcelona | Catalunya | 08035 | Spain | Details | |
Novartis Investigative Site | Hospitalet de LLobregat | Catalunya | 08907 | Spain | Details |